Cartesian Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.About RNAC
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases.
CEOCarsten Brunn
CEOCarsten Brunn
Employees66
Employees66
HeadquartersGaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
Founded
Employees66
Employees66
RNAC Key Statistics
Market cap174.74M
Market cap174.74M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume185.51K
Average volume185.51K
High today$7.35
High today$7.35
Low today$6.66
Low today$6.66
Open price$7.25
Open price$7.25
Volume139.20K
Volume139.20K
52 Week high$26.20
52 Week high$26.20
52 Week low$5.98
52 Week low$5.98
Stock Snapshot
With a market cap of 174.74M, Cartesian Therapeutics(RNAC) trades at $7.16. The stock has a price-to-earnings ratio of -0.13.
On 2025-12-09, Cartesian Therapeutics(RNAC) stock traded between a low of $6.66 and a high of $7.35. Shares are currently priced at $7.16, which is +7.5% above the low and -2.6% below the high.
The Cartesian Therapeutics(RNAC)'s current trading volume is 139.2K, compared to an average daily volume of 185.51K.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $26.20 and a 52-week low of $5.98.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $26.20 and a 52-week low of $5.98.
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%
People also own
Based on the portfolios of people who own RNAC. This list is generated using Robinhood data, and it’s not a recommendation.